Differential Expression of PMCA2 MRNA Isoforms in a Cohort of Spanish Patients with Breast Tumor Types

Overview

Journal Oncol Lett

Specialty Oncology

Date 2018 Dec 15

PMID 30546427

Citations 2

Authors

Alicia Romero-Lorca

Maria Gaibar

Angel Luis Armesilla

Ana Fernandez-Santander

Apolonia Novillo

Affiliations

Soon will be listed here.

Abstract

The present study examined the mRNA expression levels of different isoforms of the plasma membrane calcium ATPase 2 (PMCA2) gene generated by alternative splicing at the first intracellular loop (site A) and C-terminal region (site C) in 85 human breast cancer tumor and 69 adjacent non-tumor tissues. Associations were identified between the expression of PMCA2 splice isoforms and the following clinical variables: Estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status, tumor size, staging and histological classification, and lymph node status. Transcripts including splice site A or splice site C were amplified by reverse transcription-quantitative polymerase chain reaction using PMCA2 isoform-specific primers. Tumor and adjacent tissues were determined to express the different PMCA2 splice isoforms 2w, 2× and 2z (site A), and 2b (site C). The mRNA levels for these variants indicated high biological variability, but increased expression was observed in breast tumor tissues, compared with in adjacent tissues. Significantly increased PMCA2×/b expression levels were detected in breast tumor tissues histologically classified as lobulillar, compared with in ductal-types breast tumor tissues (P<0.028). Furthermore, PMCA2z expression was significantly associated with PR status (P<0.024, compared with in PR-negative tumor tissues), and PMCA2w expression was significantly associated with ER status (P<0.048, increased in ER-positive tumor tissues, compared with ER-negative tumor tissues). Finally, PMCA2b was overexpressed in HER2-positive tumor tissues, compared with in HER2-negative tumor tissues (P<0.014). The data demonstrated the differential mRNA expression of a number of splice site A and C variants of PMCA2 in breast tumor and adjacent tissues, depending on tumor hormone receptor status and histological classification. In agreement with previous data, PMCA2b was overexpressed in HER2-positive tumor tissues, indicating that high mRNA levels of this variant could be a marker of poor prognosis.

Citing Articles

Structure, Function and Regulation of the Plasma Membrane Calcium Pump in Health and Disease.

Krebs J Int J Mol Sci. 2022; 23(3).

PMID: 35162948 PMC: 8835232. DOI: 10.3390/ijms23031027.

Subtype specific targeting of calcium signaling in breast cancer.

Makena M, Rao R Cell Calcium. 2019; 85:102109.

PMID: 31783287 PMC: 6931135. DOI: 10.1016/j.ceca.2019.102109.

References

Talarico Jr E, Kennedy B, Marfurt C, Loeffler K, Mangini N . Expression and immunolocalization of plasma membrane calcium ATPase isoforms in human corneal epithelium. Mol Vis. 2005; 11:169-78. View

Cali T, Brini M, Carafoli E . Regulation of Cell Calcium and Role of Plasma Membrane Calcium ATPases. Int Rev Cell Mol Biol. 2017; 332:259-296. DOI: 10.1016/bs.ircmb.2017.01.002. View

Hill J, Williams D, LeMasurier M, Dumont R, Strehler E, Gillespie P . Splice-site A choice targets plasma-membrane Ca2+-ATPase isoform 2 to hair bundles. J Neurosci. 2006; 26(23):6172-80. PMC: 2204085. DOI: 10.1523/JNEUROSCI.0447-06.2006. View

Curry M, Roberts-Thomson S, Monteith G . PMCA2 silencing potentiates MDA-MB-231 breast cancer cell death initiated with the Bcl-2 inhibitor ABT-263. Biochem Biophys Res Commun. 2016; 478(4):1792-7. DOI: 10.1016/j.bbrc.2016.09.030. View

Krebs J . The plethora of PMCA isoforms: Alternative splicing and differential expression. Biochim Biophys Acta. 2014; 1853(9):2018-24. DOI: 10.1016/j.bbamcr.2014.12.020. View

Reinhardt T, Horst R . Ca2+-ATPases and their expression in the mammary gland of pregnant and lactating rats. Am J Physiol. 1999; 276(4):C796-802. DOI: 10.1152/ajpcell.1999.276.4.C796. View

Lopreiato R, Giacomello M, Carafoli E . The plasma membrane calcium pump: new ways to look at an old enzyme. J Biol Chem. 2014; 289(15):10261-10268. PMC: 4036151. DOI: 10.1074/jbc.O114.555565. View

Strehler E, Zacharias D . Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev. 2001; 81(1):21-50. DOI: 10.1152/physrev.2001.81.1.21. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

10.

Reinhardt T, Lippolis J, Shull G, Horst R . Null mutation in the gene encoding plasma membrane Ca2+-ATPase isoform 2 impairs calcium transport into milk. J Biol Chem. 2004; 279(41):42369-73. DOI: 10.1074/jbc.M407788200. View

11.

Stauffer T, HILFIKER H, Carafoli E, Strehler E . Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. J Biol Chem. 1993; 268(34):25993-6003. View

12.

Padanyi R, Paszty K, Hegedus L, Varga K, Papp B, Penniston J . Multifaceted plasma membrane Ca(2+) pumps: From structure to intracellular Ca(2+) handling and cancer. Biochim Biophys Acta. 2015; 1863(6 Pt B):1351-63. DOI: 10.1016/j.bbamcr.2015.12.011. View

13.

VanHouten J, Sullivan C, Bazinet C, Ryoo T, Camp R, Rimm D . PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer. Proc Natl Acad Sci U S A. 2010; 107(25):11405-10. PMC: 2895115. DOI: 10.1073/pnas.0911186107. View

14.

Antalffy G, Caride A, Paszty K, Hegedus L, Padanyi R, Strehler E . Apical localization of PMCA2w/b is enhanced in terminally polarized MDCK cells. Biochem Biophys Res Commun. 2011; 410(2):322-7. PMC: 3139432. DOI: 10.1016/j.bbrc.2011.05.147. View

15.

Desmedt C, Zoppoli G, Sotiriou C, Salgado R . Transcriptomic and genomic features of invasive lobular breast cancer. Semin Cancer Biol. 2017; 44:98-105. DOI: 10.1016/j.semcancer.2017.03.007. View

16.

HEIM R, Hug M, Iwata T, Strehler E, Carafoli E . Microdiversity of human-plasma-membrane calcium-pump isoform 2 generated by alternative RNA splicing in the N-terminal coding region. Eur J Biochem. 1992; 205(1):333-40. DOI: 10.1111/j.1432-1033.1992.tb16784.x. View

17.

Peters A, Milevskiy M, Lee W, Curry M, Smart C, Saunus J . The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin. Sci Rep. 2016; 6:25505. PMC: 4857793. DOI: 10.1038/srep25505. View

18.

Padanyi R, Xiong Y, Antalffy G, Lor K, Paszty K, Strehler E . Apical scaffolding protein NHERF2 modulates the localization of alternatively spliced plasma membrane Ca2+ pump 2B variants in polarized epithelial cells. J Biol Chem. 2010; 285(41):31704-12. PMC: 2951242. DOI: 10.1074/jbc.M110.164137. View

19.

Holton M, Yang D, Wang W, Mohamed T, Neyses L, Armesilla A . The interaction between endogenous calcineurin and the plasma membrane calcium-dependent ATPase is isoform specific in breast cancer cells. FEBS Lett. 2007; 581(21):4115-9. DOI: 10.1016/j.febslet.2007.07.054. View

20.

Jeong J, VanHouten J, Dann P, Kim W, Sullivan C, Yu H . PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer. Proc Natl Acad Sci U S A. 2016; 113(3):E282-90. PMC: 4725473. DOI: 10.1073/pnas.1516138113. View